Biomedical Offshore Value Fund, Ltd. is a hedge fund based in Grand Cayman, Cayman Islands. According to its most recent Form D, filed Dec 17, 2025, the fund has sold $772,302,554 of interests to 73 investors since its first sale in Sep 2011. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Jeffrey Jay; Alan Kelly; Charl Grobler.
Performance
No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $772,302,554Cumulative sales reported on Form D
- Investors
- 73
- First sale
- Sep 30, 2011
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Jeffrey Jay; Alan Kelly; Charl Grobler
- Latest Form D
- Dec 17, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Biomedical Offshore Value Fund, Ltd.
What is the minimum investment for Biomedical Offshore Value Fund, Ltd.?
Biomedical Offshore Value Fund, Ltd.'s latest Form D, filed Dec 17, 2025, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Biomedical Offshore Value Fund, Ltd.?
Biomedical Offshore Value Fund, Ltd. is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has Biomedical Offshore Value Fund, Ltd. raised?
Biomedical Offshore Value Fund, Ltd. reports $772,302,554 sold from 73 investors on its Form D filed Dec 17, 2025. This is cumulative sales since the offering began, not current assets or performance.
Where is Biomedical Offshore Value Fund, Ltd. based?
Biomedical Offshore Value Fund, Ltd. is based in Grand Cayman, Cayman Islands.
When did Biomedical Offshore Value Fund, Ltd. launch?
Biomedical Offshore Value Fund, Ltd. reports its first sale in Sep 2011.
Size compared with every hedge fund
Raised more than 83% of the 2,363 hedge funds based in Cayman Islands, and more than 87% of all 10,308 that report sales.
Other funds with the same team
- Statar Capital Offshore (Cayman), Ltd.$1.5B
- VR Global Offshore Fund Ltd.$1.2B
- 683 Capital Partners Offshore, Ltd.$755M
- Biomedical Value Fund, L.P.$623M
- Bronte Capital Callisto Fund LLC$214M
- 14B Parsec Offshore Fund Ltd.$193M
- VR Argentina Recovery Offshore Fund II Ltd.$175M
- Bronte Capital Ganymede Fund Ltd.$123M